Action Items

Classifying clinical trial portals

Monday, June 15, 2015

A popular driver of clinical trial portal adoption is the desire to improve investigative site staff satisfaction by providing integrated solutions that require fewer credentials, less double data entry and fewer manual paper processes. Other objectives include decreasing study timelines (especially site selection and activation), cutting study costs, improving study team oversight and moving to a paperless environment.

[Read More]

Determining the best way to redact sensitive material prior to disclosure

Friday, May 15, 2015

Transparency and disclosure of clinical trial information has been growing in importance. Providing previously confidential clinical study results for public consumption is a key step toward increasing trust between the public and the industry and encouraging information sharing that could lead to new products or therapeutic approaches.

[Read More]

BYOD for clinical trials: fact v. fiction

Friday, May 1, 2015

There is enthusiasm for the “bring your own device” (BYOD) models for clinical trials, especially for collection of electronic clinical outcome assessments (eCOAs) from patients and clinicians. Sponsors are excited about the opportunity to reduce costs—provisioning touchscreen devices for patients and sites can cost one third of a typical eCOA System.

[Read More]

Why doctors are crucial to increasing minority populations in clinical research

Wednesday, April 1, 2015

In the age of personalized medicine, it seems obvious that a clinical trial studying a new medicine should in­clude representatives from the entire population to whom it may be pre­scribed. However, for many studies currently being conducted, this is not the case. While globalization has broadened the overall diversity of participation in clinical trials, in the U.S. the patients taking part in trials are not characteristic of the popula­tion at large.

[Read More]